Clinical Trial Results Demonstrate Oshi Health’s Multidisciplinary GI Care Improves Patient Outcomes with Savings Greater than $10,000 Per Patient Within Six Months

Clinical trial results presented at the Institute for Healthcare Improvement (IHI) Forum show that virtual multidisciplinary care for gastrointestinal (GI) disorders from Oshi Health resulted in significantly higher...

AI Medical Technology reports highly promising results from clinical study in primary care facilities to validate Dermalyser – an AI-driven support tool for diagnosing...

First prospective study of its kind conducted in primary care settings, shows remarkable diagnostic performance: 95% sensitivity and 86% specificity, outperforming primary care physicians...

Theraclion Announces Positive Results of First SONOVEIN® US Trial

THERACLION has announced the results of the first SONOVEIN® trial in the United States, a major milestone towards receiving FDA approval and accessing the...

Conformal Medical Announces Positive One-Year Data from its Left Atrial Appendage Closure Performed Under Conscious Sedation Study

Conformal Medical, Inc. announced the presentation of the one-year data from the company's initial left atrial appendage occlusion (LAAO) cases with its novel CLAAS® System...

Clinical Study Shows Vista.ai Significantly Reduces Cardiac MRI Scan Time

Vista.ai, a pioneer and leader in automated MRI solutions, announced results from a clinical adaptation study on the company's One Click MRI™ software, led...

CairnSurgical Announces First Patients Treated in Europe With Breast Cancer Locator System

System Designed to Reduce the Incidence of Positive Margins – or Cancer Left Behind - After Breast Cancer Surgery CairnSurgical, Inc., an innovator striving to...

Varian Receives Investigational Device Exemption for RADIATE-VT™ Clinical Trial

Varian, a Siemens Healthineers company, has announced that the U.S. Food and Drug Administration (FDA) approved an Investigational Device Exemption (IDE) for the pivotal...

LIPOGEMS ANNOUNCES FIRST PATIENT ENROLLED IN THE U.S. ARISE STUDY FOR THE TREATMENT OF KNEE OSTEOARTHRITIS

Lipogems, a clinical stage- global medical technology company, announces the first patient enrolled on January 13, 2023, in the ARISE U.S. FDA IDE study, which...

Inari Medical enrolls first patient in ClotTriever system trial for treating deep vein thrombosis

Inari Medical announced that it enrolled the first patient in its Defiance trial for evaluating the ClotTriever system. In August 2022, Inari Medical announced the launch of...

Latest articles